Skip to main content
Log in

Clinical aspects of Alzheimer’s disease

  • Review Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Alzheimer’s disease (AD) is the most common of the dementing disorders. AD begins insidiously and progresses gradually; it is characterized clinically not only by an impairment in cognition, but also by a decline in global function, a deterioration in the ability to perform activities of daily living, and the appearance of behavioral disturbances. No definitive tests for the diagnosis are available, and AD is a diagnosis of inclusion based on patient history, physical examination, neuropsychological testing, and laboratory studies. Disease progression is highly variable, and median survival after the onset of dementia ranges from 5 to 9.3 years. Early recognition of AD allows time to plan for the future, and to treat patients before marked deterioration occurs.

(Aging Clin. Exp. Res. 13: 221–230, {dy2001)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hofmann A., Rocca W.A., Brayne C., Breteler M.M., Clarke M., Cooper B., Copeland J.R., Dartigues J.F., da Silva Droux A., Hagnell O.: The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Eurodem Prevalence Research Group. Int. J. Epidemiol. 20: 736–748, 1991.

    Article  Google Scholar 

  2. Skoog I., Nilsson L., Palmez B.: A population-based study of dementia in 85-year olds. N. Engl. J. Med. 328: 153–158, 1993.

    Article  CAS  PubMed  Google Scholar 

  3. Rocca W.A.: Frequency, distribution, and risk factors for Alzheimer’s disease. Nursing Clinics North Am. 29: 101–111, 1994.

    CAS  Google Scholar 

  4. Hebert L.E., Scherr P.A., Beckett L.A., Albert M.S., Pilgrim D.M., Chown M.J., Funkenstein H.H., Evans D.A.: Age specific incidence of Alzheimer’s disease in a community population. JAMA 273: 1354–1359, 1995.

    Article  CAS  PubMed  Google Scholar 

  5. Wolfson C., Wolfson D.B., Asgharian M., M’Lan C.M., Ostbye T., Rockwood K., Hogan D.B., for the Clinical Progression of Dementia Study Group: A Reevaluation of the Duration of Survival after the Onset of Dementia. N. Engl. J. Med. 344: 1111–1116, 2001.

    Article  CAS  PubMed  Google Scholar 

  6. Rozzini R., Sabatini T., Barbisoni P., Bellelli G., Trabucchi M.: Dementia is a major predictor of death among the Italian elderly. Neurology 54: 1014, 2000.

    Article  CAS  PubMed  Google Scholar 

  7. Baldereschi M., Di Carlo A., Maggi S., Grigoletto F., Scarlato G., Amaducci L., Inzitari D.: Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 52: 709–713, 1999.

    Article  CAS  PubMed  Google Scholar 

  8. Maurer K., Volk S., Gerbaldo H.: Auguste D and Alzheimer’s Disease. Lancet 349: 1546–1549, 1997.

    Article  CAS  PubMed  Google Scholar 

  9. Small G.W., Rabins P.V, Barry P.P., Buckholtz N.S., DeKosky S.T, Ferris S.H., Finkel S.I. Gwyther L.P., Khachaturian Z.S., Lebowitz B.D., McRae T.D., Morris J.C., Oakley F., Schneider L.S., Streim J.E., Sunderland T., Teri LA., Tune L.E.: Diagnosis and treatment of Alzheimer disease and related disorders. Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA 278: 1363–1371, 1997.

    Article  CAS  PubMed  Google Scholar 

  10. Miller B.: Clinical advances in degenerative dementias. Br. J. Psychiatr. 171: 1–3, 1997.

    Article  CAS  Google Scholar 

  11. Geldmacher D.S., Whitehouse P.J.: Evaluation of dementia. N. Engl. J. Med. 335: 330–336, 1996.

    Article  CAS  PubMed  Google Scholar 

  12. Rossor M.: Alzheimer’s disease. BMJ 307: 779–782, 1993.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Bianchetti A., Trabucchi M.: Alzheimer’s disease. In: Govoni S., Bolis C.L., Trabucchi M. (Eds.), Dementias. Biological bases and clinical approach to treatment. Springer-Verlag Italia, Milano, 1999, pp. 77–102.

    Google Scholar 

  14. Binetti G., Bianchetti A., Padovani A., Lenzi G., De Leo D., Trabucchi M.: Delusions in Alzheimer’s disease and multi-infarct dementia. Acta Neurol. Scand. 88: 5–9, 1993.

    Article  CAS  PubMed  Google Scholar 

  15. Lyketsos C.G., Steinberg M., Tschanz J.A.T., Norton M.C., Steffens D.C., Breitner J.C.S.: Mental and Behavioral Disturbances in Dementia: Findings From the Cache County Study on Memory in Aging. Am. J. Psychiatry 157: 708–714, 2000.

    Article  CAS  PubMed  Google Scholar 

  16. Cummings J.: Changes in neuropsychiatric symptoms as outcome measures in clinical trials with cholinergic therapies for Alzheimer disease. Alzh. Dis. Assoc. Disord. 11 (Suppl. 4): S1–S9, 1997.

    Google Scholar 

  17. Trabucchi M., Bianchetti A.: Delusions. Int. Psychogeriatr. 8 (Suppl. 3): 383–386, 1996.

    PubMed  Google Scholar 

  18. Bianchetti A., Scuratti A., Zanetti O., Binetti G., Frisoni G.B., Magni E., Trabucchi M.: Predictors of mortality and institutionalization in Alzheimer’s Disease patients one year after discharge from an Alzheimer’s Dementia Unit. Dementia 6: 108–112, 1995.

    CAS  PubMed  Google Scholar 

  19. Frisoni G.B., Rozzini L., Gozzetti A., Binetti G., Zanetti O., Bianchetti A., Trabucchi M., Cummings J.L.: Behavioral syndromes in Alzheimer’s disease: description and correlates. Dement. Geriatr. Cogn. Disord. 10: 130–138, 1999.

    Article  CAS  PubMed  Google Scholar 

  20. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed. 4. American Psychiatric Association, Washington, DC, 1994.

    Google Scholar 

  21. Zanetti O., Bianchetti A., Frisoni G.B., Rozzini R., Trabucchi M.: Determinants of disability in Alzheimer’s Disease. Int. J. Geriatr. Psychiatr. 8: 581–586, 1993.

    Article  Google Scholar 

  22. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M.: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944, 1984.

    Article  CAS  PubMed  Google Scholar 

  23. Gearing M., Mirra S.S., Hedreen J.C., Sumi S.H., Hansen L.A,. Heyman A.: CERAD Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45: 461–466, 1995.

    Article  CAS  PubMed  Google Scholar 

  24. Rasmusson D.X., Brandt J., Steele C., Hedreen J.C., Troncoso J.C., Folstein M.F.: Accuracy of Clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzh. Dis. Assoc. Disord. 10: 180–188, 1996.

    Article  CAS  Google Scholar 

  25. Teri L., McCurry S.M., Edland S.D., Kukull W.A., Larson E.B.: Cognitive decline in Alzheimer’s Disease: a longitudinal investigation of risk factor for accelerated decline. J. Gerontol. 50A: M49–M55, 1995.

    Article  CAS  Google Scholar 

  26. Kitwood T.: Person and process in dementia. Int. J. Geriatr. Psychiatr. 8: 541–545, 1993.

    Article  Google Scholar 

  27. Strauss M.E., Lee M.M., DiFilippo J.M.: Premorbid personality and behavior symptoms in Alzheimer disease. Arch. Neurol. 54: 257–259, 1997.

    Article  CAS  PubMed  Google Scholar 

  28. Marra C., Silveri M.C., Gainotti G.: Predictors of cognitive decline in the early stage of probable Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 11: 212–218, 2000.

    Article  CAS  PubMed  Google Scholar 

  29. Corey-Bloom J., Thal L.J., Galasko D., Folstein M., Drachman D., Raskind M., Lanska D.J.: Diagnosis and evaluation of dementia. Neurology 45: 211–218, 1995.

    Article  CAS  PubMed  Google Scholar 

  30. Richards S.S., Hendrie H.C.: Diagnosis, Management, and Treatment of Alzheimer Disease. Arch. Intern. Med. 159: 789–798, 1999.

    Article  CAS  PubMed  Google Scholar 

  31. Rabins P., Blacker D., Bland W., Bright-Long L., Cohen E., Katz I.: Practice guideline for treatment of patients with Alzheimer’s disease and other dementias of late life. Am. J. Psychiatr. 154: 1–39, 1997.

    Google Scholar 

  32. Inouye S.K., Bogardus S.T., Charpenter P.A.: A multicomponent intervention to prevent delirium in hospitalized older patients. N. Engl. J. Med. 340: 669–676, 1999.

    Article  CAS  PubMed  Google Scholar 

  33. Chan D., Brennan N.J.: Delirium: making the diagnosis, improving the prognosis. Geriatrics 54: 28–42, 1999.

    CAS  PubMed  Google Scholar 

  34. Inouye S.K., Charpentier P.A.: Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA 275: 852–857, 1996.

    Article  CAS  PubMed  Google Scholar 

  35. Yaffe K., Blackwell T., Gore R., Sands L., Reus V., Browner W.S.: Depressive Symptoms and Cognitive Decline in Non-demented Elderly Women. A Prospective Study. Arch. Gen. Psychiatr. 56: 425–430, 1999.

    Article  CAS  PubMed  Google Scholar 

  36. Chen P., Ganguli M., Mulsant B.H., DeKosky S.T.: The Temporal Relationship Between Depressive Symptoms and Dementia. A Community-Based Prospective Study. Arch. Gen. Psychiatr. 56: 261–266, 1999.

    Article  CAS  PubMed  Google Scholar 

  37. McKeith I.G., Galasko K., Kosaka K.: Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113–1124, 1996.

    Article  CAS  PubMed  Google Scholar 

  38. Geroldi C., Frisoni G.B., Bianchetti A., Trabucchi M.: Drug treatment in Lewy body dementia. Dement. Geriatr. Cogn. Disord. 8: 188–197, 1997.

    Article  CAS  PubMed  Google Scholar 

  39. Folstein M.F., Folstein S.E., McHugh P.R.: “Mini Mental State”: a practical method for grading the cognitive state of patients for the clinician. J. Psych. Res. 12: 189–198, 1975.

    Article  CAS  Google Scholar 

  40. Blessed G., Tomlinson B.E., Roth M.: The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br. J. Psychiatry 114: 797–811, 1968.

    Article  CAS  PubMed  Google Scholar 

  41. Cipolotti L., Warrington E.K.: Neuropsychological assessment. J. Neurol. Neurosurg. Psychiatry 58: 655–664, 1995.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Guttman R., Altman R.D., Nielsen N.H.: Alzheimer Disease. Report of the Council on Scientific Affairs. Arch. Fam. Med. 8: 347–353, 1999.

    Article  CAS  PubMed  Google Scholar 

  43. Magni E., Binetti G., Bianchetti A., Rozzini R., Trabucchi M.: Mini-Mental State Examination: a Normative Study in an Italian Elderly Population. Eur. J. Neurol. 3: 1–5, 1996.

    Article  Google Scholar 

  44. Reuben D.B.: Use and abuse of assessment instruments. In: Osterwail D., Reuben D.B., Rozzini R., Rubenstein L.Z., Trabucchi M. (Eds.), New frontiers in geriatric medicine. Kendall Ed., Padova (Italy), 1993, pp.17–26.

    Google Scholar 

  45. Reuben D.B., Solomon D.H.: Assessment in geriatrics. Of caveats and names. J. Am. Geriatr. Soc. 37: 570–572, 1989.

    CAS  PubMed  Google Scholar 

  46. Zanetti O., Bianchetti A., Trabucchi M.: The puzzle of functional status in mild and moderate Alzheimer’s Disease: self-report, family report, and performance-based assessement. Gerontologist 35: 148, 1995.

    Article  CAS  PubMed  Google Scholar 

  47. Zanetti O., Geroldi C., Frisoni G.B., Bianchetti A., Trabucchi M.: Contrasting results between caregiver’s report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver’s personal characteristics. J. Am. Geriatr. Soc. 47: 196–202, 1999.

    CAS  PubMed  Google Scholar 

  48. Guralnik J.M., Branch L.G., Cummings S.R., Crib J.D.: Physical performance measures in aging reserach. J. Gerontol. 44: 141–146, 1989.

    Article  Google Scholar 

  49. NIH Consensus Conference: Differential diagnosis of dementing diseases. JAMA 23: 3411–3416, 1987.

    Google Scholar 

  50. Corey-Bloom J., Thal L.J., Galasko D., Folstein M., Drachman D., Raskind M., Lanska D.J.: Diagnosis and evaluation of dementia. Neurology 45: 211–218, 1995.

    Article  CAS  PubMed  Google Scholar 

  51. Geldmacher D.S., Whitehouse P.J.: Differential diagnosis of Alzheimer’s disease. Neurology 48 (Suppl. 6): S2–S9, 1997.

    Article  CAS  PubMed  Google Scholar 

  52. Weytingh M.D., Bossuyt P.M.M., van Crevel H.: Reversible dementia: more than 10% or less than 1%? A quantitative review. J. Neurol. 242: 446–471, 1995.

    Google Scholar 

  53. Chui H., Zhang Q.: Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology’s practice parameters. Neurology 49: 925–935, 1997.

    Article  CAS  PubMed  Google Scholar 

  54. Di Luca M., Pastorino L., Bianchetti A., Perez J., Vignolo L.A., Lenzi G.L., Trabucchi M., Cattabeni F., Padovani A.: Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch. Neurol. 55: 1195–1200, 1998.

    Article  PubMed  Google Scholar 

  55. Gasparini L., Racchi M., Binetti G., Trabucchi M., Solerte B., Alkon D., Etcheberrigaray R., Gibson G., Blass J., Paoletti R., Govoni S.: Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer’s disease FASEB J. 12: 17–34, 1998.

    CAS  PubMed  Google Scholar 

  56. Growdon J.H.: Biomarkers of Alzheimer disease. Arch. Neurol. 56: 281–283, 1999.

    Article  CAS  PubMed  Google Scholar 

  57. Nagy Z.S., Smith M.Z., Esiri M.M., Barnetson L., Smith A.D.: Hyperhomocysteinaemia in Alzheimer’s disease and expression of cell cycle markers in the brain. J. Neurol. Neurosurg. Psychiatry 69: 565–566, 2000.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Andreasen N., Minthon L., Davidsson P., Vanmechelen E., Vanderstichele H., Winblad B., Blennow K.: Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch. Neurol. 58: 373–379, 2001.

    CAS  PubMed  Google Scholar 

  59. Diaz-Arrastia R.: New Biochemical Markers in Alzheimer Disease. Arch. Neurol. 58: 354–355, 2001.

    CAS  PubMed  Google Scholar 

  60. Borroni B., Colciaghi F., Pastorino L., Pettenati C., Cottini E., Rozzini L., Monastero R., Lenzi G.L., Cattabeni F., Di Luca M., Padovani A.: Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment. Arch. Neurol. 58: 442–446, 2001.

    CAS  PubMed  Google Scholar 

  61. Geldmacher D.S., Whitehouse P.J.: Differential diagnosis of Alzheimer’s disease. Neurology 48 (Suppl. 6): S2–S9, 1997.

    Article  CAS  PubMed  Google Scholar 

  62. Boss M.A.: Diagnostic approaches to Alzheimer’s disease. Biochim. Biophys. Acta 1502: 188–200, 2000.

    Article  CAS  PubMed  Google Scholar 

  63. Post S.G., Whitehouse P.J., Binstock R.H., Bird T.D., Eckert S.K., Farrer L.A., Fleck L.M., Gaines A.D., Juengst E.T., Karlinsky H., Miles S., Murray T.H., Quaid K.A., Relkin N.R., Roses A.D., St George-Hyslop P.H., Sachs G.A., Steinbock B., Truschke E.F., Zinn A.B.: The clinical introduction of genetic testing for Alzheimer disease: an ethical perspective. JAMA 277: 832–836, 1997.

    Article  CAS  PubMed  Google Scholar 

  64. Eaton M.L.: Surrogate decision making for genetic testing for Alzheimer disease. Genet. Test 3: 93–97, 1999.

    Article  CAS  PubMed  Google Scholar 

  65. McConnell L.M., Koenig B.A., Greely H.T., Raffin T.A.: Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society. Genet. Test 3: 3–12, 1999.

    Article  CAS  PubMed  Google Scholar 

  66. Frisoni G.B., Bianchetti A., Trabucchi M., Govoni S.: Diagnostic usefulness of apolipoprotein E 4 in the diagnosis of dementia. J. Neurol. Neurosurg. Psychiatry 60: 699–700, 1996.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  67. Growdon J.H.: Apolipoprotein E and Alzheimer disease. Arch. Neurol. 55: 1053–1054, 1998.

    Article  CAS  PubMed  Google Scholar 

  68. Selkoe D.J.: Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81: 741–766, 2001.

    CAS  PubMed  Google Scholar 

  69. Mayeux R., Saunders A.M., Shea S.: Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer’s disease. Alzheimer’s Disease Centers Consortium in Apolipoprotein E and Alzheimer’s Disease. N. Engl. J. Med. 338: 506–511, 1998.

    Article  CAS  PubMed  Google Scholar 

  70. Frisoni G.B., Trabucchi M.: Clinical rationale of genetic testing in dementia. J. Neurol. Neurosurg. Psychiatr. 62: 217–221, 1997.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Jagust W.J.: Neuroimaging in dementia. Neurol. Clin. 18: 885–902, 2000.

    Article  CAS  PubMed  Google Scholar 

  72. Small G.W., Leiter F.: Neuroimaging for diagnosis of dementia. J. Clin. Psychiatr. 59 (Suppl. 11): 4–7, 1998.

    Google Scholar 

  73. Laakso M.P., Frisoni G.B., Kononen M., Mikkonen M., Beltramello A., Geroldi C., Bianchetti A., Trabucchi M., Soininen H., Aronen H.J.: Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer’s disease: a morphometric MRI study. Biol. Psychiatry 47:1056-1063, 2000.

  74. Frisoni G.B., Pizzolato G., Govoni S., Bianchetti A., Ferlin G., Trabucchi M.: Single Photon Emission Computed Thomography with [99mTc]-HM-PAO and [123I]-IBZM in Alzheimer’s

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Bianchetti M.D..

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bianchetti, A., Trabucchi, M. Clinical aspects of Alzheimer’s disease. Aging Clin Exp Res 13, 221–230 (2001). https://doi.org/10.1007/BF03351480

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03351480

Key words

Navigation